ENTITY
OrbusNeich

OrbusNeich (6929 HK)

6
Analysis
Health Care • Hong Kong
OrbusNeich designs, develops, manufactures, and markets interventional medical devices for treating vascular diseases, including percutaneous coronary intervention (PCI) and percutaneous transluminal angioplasty (PTA) procedures. Their product portfolio includes a range of balloons, coronary stents, and specialty catheters. The company is headquartered in Hong Kong, China, and was founded in 2000.
more
Exchange Announcement • 07 Sep 2026 16:30

Interim Report 2026

Exchange Announcement • 17 Aug 2026 12:07

Change Of Officers And Company Secretary

Exchange Announcement • 14 Aug 2026 12:04

Declaration Of Interim Dividend And Closure Of Register Of Members (Updated)

Exchange Announcement • 13 Aug 2026 16:31

Declaration Of Interim Dividend And Closure Of Register Of Members

Exchange Announcement • 13 Aug 2026 16:30

Announcement Of Interim Results For The Six Months Ended June 30, 2026

x